The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Infectious Diseases

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/646613PMID 19877844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

  2010cited by this paper
• Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

  2008cited by this paper
• Malaria. Did they really say ... eradication?

  2007cited by this paper
• The decline in paediatric malaria admissions on the coast of Kenya

  2007cited by this paper
• Revisiting the Basic Reproductive Number for Malaria and Its Implications for Malaria Control

  2007cited by this paper
• Did They Really Say ... Eradication?

  2007cited by this paper
• Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine

  2003cited by this paper
• Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

  2002cited by this paper
• Changes in malaria incidence after mass drug administration in Nicaragua.

  1983cited by this paper
• The Garki project: Research on the epidemiology and control of malaria in the Sudan savanna of West Africa

  1980cited by this paper

• Plasmodium vivax antigen candidate prediction improves with the addition of Plasmodium falciparum data

  2024cites this paper
• Positive-unlabeled learning identifies vaccine candidate antigens in the malaria parasite Plasmodium falciparum

  2024influential citation
• Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data

  2023cites this paper
• Nanopore sequencing for real-time genomic surveillance of Plasmodium falciparum

  2023cites this paper
• Sporozoite immunization: innovative translational science to support the fight against malaria

  2023cites this paper
• Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana

  2023cites this paper
• Malaria Vaccines

  2022cites this paper
• Low Dose Gamma Irradiation of Trypanosoma evansi Parasites Identifies Molecular Changes That Occur to Repair Radiation Damage and Gene Transcripts That May Be Involved in Establishing Disease in Mice Post-Irradiation

  2022cites this paper
• Harnessing liver-resident memory T cells for protection against malaria

  2021cites this paper
• Methods for studying memory B-cell immunity against malaria

  2020cites this paper
• Designing a multi-epitope vaccine against blood-stage of Plasmodium falciparum by in silico approaches.

  2020cites this paper
• Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population.

  2020cites this paper
• The Controlled Human Malaria Infection Experience at the University of Maryland.

  2019cites this paper
• Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge

  2019cites this paper
• Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

  2018cites this paper
• Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

  2018cites this paper
• Mathematical model for the in-host malaria dynamics subject to malaria vaccines

  2018cites this paper
• Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: Implication for vaccine development

  2017cites this paper
• Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine

  2016cites this paper
• Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

  2016cites this paper
• Malaria Vaccine Development: Recent Advances alongside the Barriers

  2016cites this paper
• Correction: Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

  2016cites this paper
• Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

  2016cites this paper
• A REVIEW ABOUT MALARIA AND ITS TREATMENT

  2015cites this paper
• Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates

  2015cites this paper
• Funcional analysis of genes differentially expressed in salivary glands of Anopheles coluzzii and Anopheles stephensi in response to infection by Plasmodium berghei

  2015cites this paper
• Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines

  2015cites this paper
• Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice

  2015cites this paper
• Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.

  2015cites this paper
• The case for a rational genome-based vaccine against malaria

  2015influential citation
• Designing malaria vaccines to circumvent antigen variability

  2015cites this paper
• Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum

  2015cites this paper
• Limited genetic diversity and purifying selection in Iranian Plasmodium falciparum Generative Cell Specific 1 (PfGCS1), a potential target for transmission-blocking vaccine.

  2014cites this paper
• A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites

  2014cites this paper
• Malaria Vaccine: A Future Hope to Curtail the Global Malaria Burden

  2014cites this paper
• Karunamoorthi : Malaria vaccine : A new hope in war against malaria International Journal of Preventive Medicine

  2014cites this paper
• The Jeremiah Metzger lecture: new additions to the toolbox for global malaria eradication.

  2014cites this paper
• THE NEW ADDITIONS TO THE TOOLBOX FOR GLOBAL MALARIA ERADICATION

  2014cites this paper
• Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial

  2013cites this paper
• The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya

  2013cites this paper
• A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.

  2013cites this paper
• Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

  2013cites this paper
• Papel do receptor P2X7 nos fagócitos em resposta à infecção pelo Plasmodium chabaudi.

  2013cites this paper
• Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines

  2013cites this paper
• Immune mechanisms in malaria: new insights in vaccine development

  2013cites this paper
• Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?

  2012cites this paper
• Innate recognition of malarial parasites by mammalian hosts.

  2012cites this paper
• Vaccines for malaria: how close are we?

  2012cites this paper
• Control and elimination of Plasmodium vivax.

  2012cites this paper
• Prospects for malaria elimination in non-Amazonian regions of Latin America.

  2012cites this paper
• Malaria Genomics and the Developing World

  2012cites this paper
• Ethics of vaccination programs.

  2011cites this paper
• A field trial to assess a blood-stage malaria vaccine.

  2011cites this paper
• Preliminary characterization of N-trimethylchitosan as a nanocarrier for malarie vaccine

  2011cites this paper
• Impact on Malaria Parasite Multiplication Rates in Infected Volunteers of the Protein-in-Adjuvant Vaccine AMA1-C1/Alhydrogel+CPG 7909

  2011cites this paper
• Malaria: clinical and epidemiological aspects.

  2011cites this paper
• CHAPTER 96 – Malaria

  2011cites this paper
• A Research Agenda for Malaria Eradication: Drugs

  2011cites this paper
• Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

  2011cites this paper
• Is vaccine the magic bullet for malaria elimination? A reality check.

  2010cites this paper
• Review Article Malaria Vaccines

  2010cites this paper
• Gene-expression analysis for prediction of RTS,S-induced protection in humans

  2010cites this paper
• Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine

  2010cites this paper
• Malaria vaccine design: immunological considerations.

  2010cites this paper
• Cost-Effectiveness of Intermittent Preventive Treatment of Malaria in Pregnancy in Southern Mozambique

  2010cites this paper
• Is vaccine the magic bullet for malaria elimination? A reality check

  2010cites this paper
• Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

  2010cites this paper
• Anti-malarial market and policy surveys in sub-Saharan Africa

  2010cites this paper